Catherine R. Sears

Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement

Catherine R. Sears, Tobias Peikert, Jennifer D. Possick et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 142 citations · Full text

Life Sciences, Immunology, Oncology +16

Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement

Peter J. Mazzone, Catherine R. Sears, Douglas A. Arenberg et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 138 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Chest Physicians Research Statement

Anne V. Gonzalez, Gerard A. Silvestri, Daniël A. Korevaar et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Radiology +12

Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways

Catherine R. Sears, John J. Turchi · Journal of Biological Chemistry · 2012 · 65 citations · Full text

Life Sciences, Molecular Biology, Oncology +13

DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer

Catherine R. Sears, Sean A. Cooney, Helen Chin-Sinex et al. · DNA repair · 2016 · 60 citations

Medicine, Molecular Biology, Oncology +17